Molecular Level Dissection of Critical Spike Mutations in SARS-CoV-2 Variants of Concern (VOCs): A Simplified Review
Overview
Authors
Affiliations
SARS-CoV-2 virus during its spread in the last one and half year has picked up critical changes in its genetic code i.e. mutations, which have leads to deleterious epidemiological characteristics. Due to critical role of spike protein in cell entry and pathogenesis, mutations in spike regions have been reported to enhance transmissibility, disease severity, possible escape from vaccine-induced immune response and reduced diagnostic sensitivity/specificity. Considering the structure-function impact of mutations, understanding the molecular details of these key mutations of newly emerged variants/lineages is of urgent concern. In this review, we have explored the literature on key spike mutations harbored by , , and 'variants of concern' (VOCs) and discussed their molecular consequences in the context of resultant virus biology. Commonly all these VOCs i.e. and lineages have decisive mutation in Receptor Binding Motif (RBM) region and/or region around Furin cleavage site (FCS) of spike protein. In general, mutation induced disruption of -molecular interaction enhances molecular flexibility leading to exposure of spike protein surface in these lineages to make it accessible for -molecular interaction with hACE2. A disruption of spike antigen-antibody -molecular interactions in epitope region due to the chemical nature of substituting amino acid hampers the neutralization efficacy. Simplified surveillance of mutation induced changes and their consequences at molecular level can contribute in rationalizing mutation's impact on virus biology. It is believed that molecular level dissection of these key spike mutation will assist the future investigations for a more resilient outcome against severity of COVID-19.
Association of COVID with Mycosis in General.
Kaur G, Kaur R, Sumanpreet , Kaur M Infect Disord Drug Targets. 2024; 24(6):e190124225866.
PMID: 38251692 DOI: 10.2174/0118715265266815231130063931.
Defining neutralization and allostery by antibodies against COVID-19 variants.
Tulsian N, Palur R, Qian X, Gu Y, DO Shunmuganathan B, Samsudin F Nat Commun. 2023; 14(1):6967.
PMID: 37907459 PMC: 10618280. DOI: 10.1038/s41467-023-42408-x.
Gopalan V, Chandran A, Arumugam K, Sundaram M, Velladurai S, Govindan K J Glob Infect Dis. 2023; 15(2):43-51.
PMID: 37469462 PMC: 10353649. DOI: 10.4103/jgid.jgid_178_22.
Yang H, Chen Y, Jiang D, Feng X, Xu Y, Wei J Antib Ther. 2023; 6(2):97-107.
PMID: 37077474 PMC: 10108555. DOI: 10.1093/abt/tbad003.
Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients.
Giotis E, Cil E, Brooke G Viruses. 2022; 14(12).
PMID: 36560732 PMC: 9788624. DOI: 10.3390/v14122728.